ANDA 203865, held by Naari Pte. Ethinyl Estradiol; Norgestimate.
As of Nov 16, 2026, ANDA 203865 (Norgestimate And Ethinyl Estradiol), held by Naari Pte, was first approved by FDA on Oct 27, 2015, with 1 approved supplement and 0 published complete response letters.
Femynor Tablets are indicated for use by females of reproductive potential to prevent pregnancy. Femynor are estrogen/progestin COCs, indicated for use by women to prevent pregnancy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 27, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Norgestimate And Ethinyl Estradiol0.035MG;0.25MG · tablet;oral-28 | Ethinyl Estradiol; Norgestimate | Discontinued |
| Apr 29, 2022 | Supplement 7Labeling · Standard review | Approved | None posted |
| Oct 27, 2015 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters